\-\ Texto\\:\\ \ \(0\)\
\-\ minimal\\ fever\\.\\ \\ remainder\\ of\\ examination\\ unremarkable\\.\ \(0\)\
\-\ this\\ patient\\ is\\ newly\\ diagnosed\\ and\\ undergoing\\ treatment\\.\\ \\ routine\\ surveillance\\ imaging\\ will\\ be\\ performed\\ to\\ document\\ progression\\ or\\ resolution\\.\ \(0\)\
\-\ bilateral\\ hilar\\ adenopathy\\ with\\ right\\ paratracheal\\ adenopathy\\.\\ \\ no\\ parenchymal\\ disease\\ evident\\.\ \(0\)\
\-\ sarcoid\\ \\-\\ confirmed\\ via\\ biopsy\\.\ \(0\)\
\-\ sarcoidosis\ \(108\)\
\-\ lymphoma\ \(373\)\
\-\ tb\\ \\(although\\ this\\ patient\\ is\\ ppd\\ negative\\)\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ pneumoconiosis\\ \\(silicosis\\,\\ berylliosis\\)\ \(0\)\
\-\ leukemia\ \(70\)\
\-\ 26\\ yo\\ african\\-american\\ female\\ presents\\ with\\ fever\\ and\\ \\"flu\\-like\\"\\ symptoms\\.\\ \\ no\\ unusual\\ occupational\\ exposures\\.\\ \\ acute\\ onset\\ of\\ symptoms\\.\\ \\ no\\ weight\\ loss\\.\\ \\ non\\-smoker\\.\\ hiv\\ and\\ ppd\\ negative\\.\ \(0\)\
\-\ these\\ radiographs\\ exhibit\\ the\\ classic\\ \\"1\\-2\\-3\\ sign\\"\\ of\\ bilateral\\ hilar\\ adenopathy\\ and\\ right\\ paratracheal\\ adenopathy\\ seen\\ most\\ frequently\\ in\\ sarcoidosis\\.\\ \\ as\\ this\\ patient\\ only\\ exhibits\\ adenopathy\\ without\\ evidence\\ of\\ lung\\ parenchymal\\ involvement\\,\\ this\\ would\\ be\\ categorized\\ as\\ stage\\ 1\\ sarcoidosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adenopathy\\:\\ 0\\.12941779353300145\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.07876921155847423\ \(0\)\
\-\ ppd\\:\\ 0\\.0756111821217009\ \(0\)\
\-\ paratracheal\\:\\ 0\\.07278615675056832\ \(0\)\
\-\ hilar\\:\\ 0\\.05841809315533956\ \(0\)\
\-\ parenchymal\\:\\ 0\\.05714827084524134\ \(0\)\
\-\ flu\\-like\\:\\ 0\\.05525422614562281\ \(0\)\
\-\ 1\\-2\\-3\\:\\ 0\\.05525422614562281\ \(0\)\
\-\ berylliosis\\:\\ 0\\.04902095586076461\ \(0\)\
\-\ exposures\\:\\ 0\\.04778067316148601\ \(0\)\
\-\ non\\-smoker\\:\\ 0\\.04430566891817995\ \(0\)\
\-\ categorized\\:\\ 0\\.04306538621890134\ \(0\)\
\-\ document\\:\\ 0\\.04154740287662781\ \(0\)\
\-\ pneumoconiosis\\:\\ 0\\.04069595292455974\ \(0\)\
\-\ silicosis\\:\\ 0\\.04030712017734921\ \(0\)\
\-\ fever\\:\\ 0\\.03933690648370022\ \(0\)\
\-\ occupational\\:\\ 0\\.038942013405497834\ \(0\)\
\-\ exhibits\\:\\ 0\\.038942013405497834\ \(0\)\
\-\ newly\\:\\ 0\\.03863962046283911\ \(0\)\
\-\ exhibit\\:\\ 0\\.03863962046283911\ \(0\)\
\-\ african\\-american\\:\\ 0\\.03754885413579707\ \(0\)\
\-\ surveillance\\:\\ 0\\.036183747363945695\ \(0\)\
\-\ negative\\:\\ 0\\.034722723284011894\ \(0\)\
\-\ hiv\\:\\ 0\\.03223116312966516\ \(0\)\
\-\ sarcoid\\:\\ 0\\.02982790221172234\ \(0\)\
\-\ leukemia\\:\\ 0\\.02982790221172234\ \(0\)\
\-\ symptoms\\:\\ 0\\.028974931658478083\ \(0\)\
\-\ progression\\:\\ 0\\.028919525391147363\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.028573265818119958\ \(0\)\
\-\ undergoing\\:\\ 0\\.028507112997838275\ \(0\)\
\-\ bilateral\\:\\ 0\\.02821520720155706\ \(0\)\
\-\ unusual\\:\\ 0\\.028118280250627743\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.028023802748057727\ \(0\)\
\-\ tb\\:\\ 0\\.027993456178054977\ \(0\)\
\-\ remainder\\:\\ 0\\.027401542048873826\ \(0\)\
\-\ 26\\:\\ 0\\.026909564759216503\ \(0\)\
\-\ evident\\:\\ 0\\.026600296908354207\ \(0\)\
\-\ this\\:\\ 0\\.026153393559568246\ \(0\)\
\-\ frequently\\:\\ 0\\.025194085956530304\ \(0\)\
\-\ resolution\\:\\ 0\\.02507224291866275\ \(0\)\
\-\ via\\:\\ 0\\.02495254385818398\ \(0\)\
\-\ stage\\:\\ 0\\.02479615257774385\ \(0\)\
\-\ routine\\:\\ 0\\.02330916118469386\ \(0\)\
\-\ minimal\\:\\ 0\\.02288761884626393\ \(0\)\
\-\ classic\\:\\ 0\\.02227384271298008\ \(0\)\
\-\ confirmed\\:\\ 0\\.021859861245488416\ \(0\)\
\-\ diagnosed\\:\\ 0\\.02137547725710888\ \(0\)\
\-\ involvement\\:\\ 0\\.021305705147128002\ \(0\)\
\-\ weight\\:\\ 0\\.020836365885312007\ \(0\)\
\-\ would\\:\\ 0\\.02068684951307544\ \(0\)\
\-\ biopsy\\:\\ 0\\.02062376354854939\ \(0\)\
\-\ sign\\:\\ 0\\.020139091848735174\ \(0\)\
\-\ although\\:\\ 0\\.01963217197671159\ \(0\)\
\-\ unremarkable\\:\\ 0\\.019245349786952793\ \(0\)\
\-\ disease\\:\\ 0\\.019003231853274887\ \(0\)\
\-\ radiographs\\:\\ 0\\.01841000572246349\ \(0\)\
\-\ onset\\:\\ 0\\.018349804257994217\ \(0\)\
\-\ will\\:\\ 0\\.018186945703259468\ \(0\)\
\-\ examination\\:\\ 0\\.018070905003228336\ \(0\)\
\-\ be\\:\\ 0\\.01792866290263849\ \(0\)\
\-\ as\\:\\ 0\\.017586088515566364\ \(0\)\
\-\ no\\:\\ 0\\.017560084708240855\ \(0\)\
\-\ yo\\:\\ 0\\.01749218723335212\ \(0\)\
\-\ patient\\:\\ 0\\.017481467977885468\ \(0\)\
\-\ only\\:\\ 0\\.01747899087404718\ \(0\)\
\-\ loss\\:\\ 0\\.01687390593515945\ \(0\)\
\-\ lung\\:\\ 0\\.016837817144481265\ \(0\)\
\-\ lymphoma\\:\\ 0\\.016613596152309427\ \(0\)\
\-\ performed\\:\\ 0\\.016208015858689244\ \(0\)\
\-\ evidence\\:\\ 0\\.015241106009298488\ \(0\)\
\-\ these\\:\\ 0\\.015128195183386666\ \(0\)\
\-\ metastatic\\:\\ 0\\.014633397303510818\ \(0\)\
\-\ acute\\:\\ 0\\.014352920606166634\ \(0\)\
\-\ 1\\:\\ 0\\.013832152162991202\ \(0\)\
\-\ without\\:\\ 0\\.013687164396994286\ \(0\)\
\-\ imaging\\:\\ 0\\.013619549826228589\ \(0\)\
\-\ most\\:\\ 0\\.013420647222639973\ \(0\)\
\-\ \\-\\:\\ 0\\.012460737814342608\ \(0\)\
\-\ right\\:\\ 0\\.01226709808313492\ \(0\)\
\-\ female\\:\\ 0\\.011950750145903629\ \(0\)\
\-\ presents\\:\\ 0\\.01187513126195868\ \(0\)\
\-\ treatment\\:\\ 0\\.011766101765992429\ \(0\)\
\-\ seen\\:\\ 0\\.011487262687535306\ \(0\)\
\-\ \\(\\:\\ 0\\.009828050697195381\ \(0\)\
\-\ \\)\\:\\ 0\\.009707995811065375\ \(0\)\
\-\ is\\:\\ 0\\.0076502146719010285\ \(0\)\
\-\ or\\:\\ 0\\.00681307992492318\ \(0\)\
\-\ and\\:\\ 0\\.004898204237611386\ \(0\)\
\-\ \\,\\:\\ 0\\.003683130143092345\ \(0\)\
\-\ \\.\\:\\ 0\\.0036224016425863547\ \(0\)\
\-\ of\\:\\ 0\\.0031701714502853995\ \(0\)\
\-\ to\\:\\ 0\\.002905225227503308\ \(0\)\
\-\ in\\:\\ 0\\.0028666478240833666\ \(0\)\
\-\ with\\:\\ 0\\.0015918935522433978\ \(0\)\
\-\ the\\:\\ 0\\.0009404713245144612\ \(0\)\
